NICE new drug plan
September 9, 2015
A COLLABORATION between 32
international public and private
partners including regulators,
patients, academia, and industry
representatives has been
established under the auspices
of the UK National Institute for
Health and Care Excellence (NICE)
to identify activities that can make
the development and regulation of
medicines more efficient.
Dubbed the Accelerated
Development of Appropriate
Patient Therapies (ADAPT SMART),
and funded by the EU Innovative
Medicines Initiative, the project
seeks to develop a Medicines
Adaptive Pathways to Patients
(MAPPs) model that is responsive
to the needs of patients, regulators,
healthcare professionals and
members of the industry.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Sep 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Sep 15